Halt Aging in Survivors of Blood Cancers
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
Belantamab Mafodotin or Daratumumab With Bortezomib, Lenalidomide and Dexamethasone for Newly Diagnosed Multiple Myeloma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE2
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE2
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE3
A Study of BL-M24D1 in Patients With Relapsed or Refractory Multiple Myeloma and Other Hematologic Malignancies
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy
- Status
- RECRUITING
- Phase
- NA
CAR19-BCMA Dual-target CAR-T in the Treatment of Relapsed / Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Universal CAR-T Cell Therapy for MM
- Status
- RECRUITING
- Phase
- NA
ELDORADO: Elranatamab Versus Daratumumab in Combination With RVd Lite for Newly Diagnosed Transplant Ineligible/Deferred Multiple Myeloma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
In VIVO CAR-T Therapy for Relapsed/Refractory Hematological Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard of Care in Participants With Relapsed-Refractory Multiple Myeloma (RRMM)
- Status
- RECRUITING
- Phase
- PHASE2
An AI-Generated, Personalized Question Prompt List Intervention for Patients With Hematologic Cancers
- Status
- RECRUITING
- Phase
- NA
A Dietary Study for People With Multiple Myeloma
- Status
- RECRUITING
- Phase
- NA
A Multicenter Prospective Observational Cohort Study Evaluating the Impact of Cancer-Directed Treatment and Medication Use, Including Cannabis Use, in Multiple Myeloma Patients
- Status
- RECRUITING
- Phase
- N/A
Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With Isatuximab in Participants With RRMM
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With Feladilimab (GSK3359609) in Participants With RRMM
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Karyopharm Expanded Access Program for Selinexor
- Status
- AVAILABLE
- Phase
- N/A
High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT)
- Status
- RECRUITING
- Phase
- N/A